IDT

The companies will develop a portfolio of indexed adapters specifically designed for multiplex NGS and optimized for use on Illumina systems such as the NovaSeq.

The agreement provides researchers with local customer care, and allows them to order reagents from within the country rather than importing them. 

The technology has been a core capability of the firm, which is expanding its suite of products to address the broader needs of genomics researchers.

The acquisition of GeneWorks' oligo business widens IDT's reach in the Asia-Pacific region, the company said.

IDT has licensed the CRISPR/Cpf1 RNA-guided editing system from the Broad Institute and intends to sell it to pharmaceutical and other commercial labs.

The Hereditary Cancer Solution combines target capture probes from Integrated DNA Technologies with specialized analytics developed by Sophia.

The acquisition of San Diego-based ValueGene expands IDT's presence in Southern California. 

The companies will combine their respective technologies and expertise to develop new products for low-input, targeted RNA-seq applications.

As the interference proceeding to resolve claims in foundational CRISPR patents draws near, Caribou has given IDT worldwide rights to sell RUO reagents. 

The partnership will pair Sophia's informatics infrastructure with IDT's panel to provide an NGS-based solution for routine clinical diagnostics.

Pages

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.